header
Image from OpenLibrary

Viral kinetic changes after 4 weeks and its relation to response to Peg - INF therapy in chronic HCV genotype 4 patients / Ahmed Elsayed Taha Elsayed ; Supervised Gamal Eldin Esmat , Rasha Ahmed Abdelaziz , Dina Sabry Abdelfattah

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Ahmed Elsayed Taha Elsayed , 2014Description: 108 P. : charts ; 25cmOther title:
  • قياس نسبة التغيرات العددية لفيروس سى بعد الأسبوع الرابع من العلاج بالانترفيرون المقوى فى مرضى الالتهاب الكبدى الوبائى المزمن سى من النوع الرابع [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine Summary: In patients with chronic hepatitis C virus (HCV) infection scheduled for a 48 week treatment period, premature discontinuation of treatment was previously recommended if HCV - RNA levels remained detectable at week 24 of therapy. Considering the number of side effects and treatment costs, measurement of initial viral decline during therapy may identify virologic nonresponse earlier than 24 weeks. To assess changes in the viral load at week 4 of treatment as a predictor for treatment outcome and to update genotype status of HCV. We retrospectively analyzed 152 Egyptian patients treated with pegylated interferon alfa and ribavirin for 48 weeks
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.M.Sc.2014.Ah.V (Browse shelf(Opens below)) Not for loan 01010110063772000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.M.Sc.2014.Ah.V (Browse shelf(Opens below)) 63772.CD Not for loan 01020110063772000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine

In patients with chronic hepatitis C virus (HCV) infection scheduled for a 48 week treatment period, premature discontinuation of treatment was previously recommended if HCV - RNA levels remained detectable at week 24 of therapy. Considering the number of side effects and treatment costs, measurement of initial viral decline during therapy may identify virologic nonresponse earlier than 24 weeks. To assess changes in the viral load at week 4 of treatment as a predictor for treatment outcome and to update genotype status of HCV. We retrospectively analyzed 152 Egyptian patients treated with pegylated interferon alfa and ribavirin for 48 weeks

Issued also as CD

There are no comments on this title.

to post a comment.